junction.' The serum ferritin concentration in the remaining eight patients ranged from 19 to 251 ,ug/l and they had not received any abnormal amounts ofblood transfusion. Large joints were not affected in these patients. Six of the 10 patients had evidence of renal osteodystrophy and underwent parathyroidectomy.
We concur with Dr N R Cary and coworkers (29 November, p 1392) that amyloid deposits are a feature of carpal tunnel syndrome in patients undergoing regular haemodialysis treatment and are related to i32 microglobulin accumulation. However, we did not observe iron overload in these patients. We wonder whether the haemosiderin deposits they found in the synovial tissue of joints could result from minor haemorrhages for mechanical reasons in these susceptible patients. Macrocytic anaemia in patients treated with sulphasalazine for rheumatoid arthritis SIR,-We note that the seven patients of Dr P J Prowse and colleagues who developed macrocytosis were from a group of 50 receiving sulphasalazine for progressive erosive rheumatoid disease. The authors infer from the data presented that the development of macrocytic anaemia due to sulphasalazine therapy in this situation is therefore quite common. We do not, however, think that this conclusion is entirely justified from their data. Of the seven cases described, four had an important potential cause of folate deficiency quite separate from sulphasalazine therapy. Thus one had malabsorption with bacterial overgrowth, a second coeliac disease, a third a "poor diet," and a fourth chronic haemolysis. In none ofthese patients can sulphasalazine be concluded to be the cause of macrocytosis. Of the other three patients reported, none appeared to have undergone bone marrow examination, and therefore megaloblastic anaemia was not confirmed. Also the increase in mean corpuscular volume while taking sulphasalazine was at most modest in one of the subjects (case 7). In all three cases the red cell folate value was below the lower limit of normal, but no data were given on red cell folate before sulphasalazine therapy. Modest increases in mean cell volume in the absence of folate deficiency have been reported in patients with rheumatoid arthritis taking sulphasalazine' and we have seen a number of cases in which a modest increase in mean cell volume occurred during sulphasalazine therapy, with a subsequent spontaneous fall and no evidence of folate deficiency or haemolysis.
The data presented are not adequate to justify a diagnosis of sulphasalazine induced folate deficiency in most of these patients. The increase in molluscum contagiosum SIR,-Dr J D Oriel brings to our attention the increase in the incidence of molluscum contagiosum (10 January, p 74). I would like to add a few points about its management. Identification of the lesions is not as easy as it may seem, and they are often mistaken for condylomata acuminata. When a patient presents with lesions of molluscum contagiosum in a busy clinic their removal will probably be time consuming, each one needing to be removed individually.
The standard descriptions mention phenol, but this might be considered unsafe, especially if the operator's hands are unsteady. Tincture of iodine introduced into the tumour with the pointed end of a wooden stick is probably safer.' The removal of the lesions is usually done in the outpatient department with the operator having to press on the lesion with his thumb nail, usually ungloved (in fact they are not easy to remove in gloves). There is usually some oozing of blood. In homosexuals molluscum contagiosum is often found on the face and around the natal cleft. The lesions are often worse and more widespread in individuals who are infected with the human immunodeficiency virus,2 who are often also positive for hepatitis B surface antigen. Is 
